External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home MDA 2023
Roche and Genentech at

MDA 2023

March 19 - March 22
Texas, USA/ Virtual (Hybrid)
mdaconference.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
12:00 PM
Duration 15mins Chantilly Ballroom West
One-year data from ENDEAVOR, a Phase 1b trial of delandistrogene moxeparvovec in patients with DMD
CM Proud, CM Zaidman, CM McDonald, S Mason, M Guridi, S Wang, C Reid, E Darton, C Wandel, S Lewis, J Malhotra, DA Griffin, RA Potter, LR Rodino-Klapac, JR Mendell
Neuroscience | Duchenne Muscular Dystrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.